QJ ANTIINFECTIVES FOR SYSTEMIC USE
QJ05 ANTIVIRALS FOR SYSTEMIC USE
QJ05A DIRECT ACTING ANTIVIRALS
QJ05AG Non-nucleoside reverse transcriptase inhibitors
QJ05AG05 rilpivirine
Last updated: 2022-02-03
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Skøyen
0213 Oslo
Norway
Visiting/delivery address:
Sandakerveien 24C
Bygg C
0473 Oslo
Norway
Tel: +47 21 07 81 60
E-mail:
Copyright/Disclaimer
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Skøyen
0213 Oslo
Norway
Visiting/delivery address:
Sandakerveien 24C
Bygg C
0473 Oslo
Norway
Tel: +47 21 07 81 60
E-mail:
Copyright/Disclaimer